To study the effectiveness of three ayurvedic drug combination in common cold in children.
Not Applicable
- Conditions
- Health Condition 1: J00- Acute nasopharyngitis [common cold]
- Registration Number
- CTRI/2021/02/031010
- Lead Sponsor
- Dr Mahesh Narayan Gupta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Physical examination & clinically significant
abnormal lab investigation at pre study.
2.Having allergy history.
3.Who fulfill diagnostic criteria of pratishyaya
Exclusion Criteria
1.Below 2yrs & above 16 yrs
2.Congenital defects & disorders
3.Having severe cardiovascular,gastrointestinal &
renal disease.
4.Hematological, Neurological & psychiatric disease.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method DIGNOSTIC CRITERIA- <br/ ><br>1.Nasal blockage <br/ ><br>2.Kadu nasa,netra,gala,talu <br/ ><br>3.Shiro gurutva <br/ ><br>4.Fever <br/ ><br>5.Sneezing <br/ ><br>6.Swarabheda <br/ ><br>7.Cough <br/ ><br>8.Lacrimation <br/ ><br>9.Runny nose <br/ ><br>10.Sore throat <br/ ><br> We select the patient if he/she present the minimum five criteria positive. <br/ ><br>Timepoint: The observation of patients will be carried out during the trial at every 5 days interval for 20 days and after completion of trial 15 days interval. Both objective and subjective parameters as per requirement will be taken. Next follow up should be taken at 45 days for assesment of recovery.
- Secondary Outcome Measures
Name Time Method DIGNOSTIC CRITERIA- <br/ ><br>1.Nasal blockage <br/ ><br>2.Kadu nasa,netra,gala,talu <br/ ><br>3.Shiro gurutva <br/ ><br>4.Fever <br/ ><br>5.Sneezing <br/ ><br>6.Swarabheda <br/ ><br>7.Cough <br/ ><br>8.Lacrimation <br/ ><br>9.Runny nose <br/ ><br>10.Sore throat <br/ ><br> We select the patient if he/she present the minimum five criteria positive. <br/ ><br>Timepoint: The observation of patients will be carried out during the trial at every 7days interval for 20 days and after completion of trial 15 days interval. Both objective and subjective parameters as per requirement will be taken. Next follow up should be taken at 45 days for assesment of recovery.